Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +10.1% | +1273.9% | 3 / 3 | -6.4% | -3.74 pp | +2.76 pp | +9.8% | 0.02 | 10.37 | 513 | −6,4% | 101 | +8,8% | 10.37 | 18.64 | −44,4% |
| Pts | 0 | 12 | 12 | 0 | 0 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 14.600 (close price on 2026-10-19)EPS (TTM): 1.408
Financial charts
1.Revenue & growth
VND bn513Q2/26
1.Revenue & growth
VND bn513Q2/26
2.Profit & growth
VND bn100,0Q2/26
3.Profit mix (Penman)
VND bn537Q2/26
4.Margins & cost structure
%17.1%Q2/26
5.Returns & cash cycle
% · days1.7%Q2/26
6.Earnings quality & cash
VND bn31,1Q2/26
7.Asset structure
VND bn5.795Q2/26
8.Funding & debt health
VND bn · times5.795Q2/26
9.Revenue backlog
VND bn63,1Q2/26
10.Valuation
times · %10,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %286Q2/26
Adjusted EPS growth, latest quarter
10.1%
Average adjusted EPS growth, 3 quarters
13,7× higher
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26